SVB Leerink analyst Mani Foroohar maintains Moderna (NASDAQ:MRNA) with a Underperform and raises the price target from $70 to $77.
Lockheed Martin Ventures Invests In High Performance Electric Motor Manufacturer H3X
H3X Technologies today announced the completion of an investment by Lockheed Martin Ventures (LMV), the venture arm of Lockheed Martin Corporation (NYSE:LMT), a global security and aerospace company. H3X designs and